Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial
Open Access
- 29 February 2012
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 14 (3), 278-286
- https://doi.org/10.1093/eurjhf/hfr177
Abstract
Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical variables for the diagnosis of pneumonia in patients presenting to emergency departments (EDs) with a chief complaint of shortness of breath. The BACH trial was a prospective, international, study of 1641 patients presenting to EDs with dyspnoea. Blood samples were analysed for PCT and other biomarkers. Relevant clinical data were also captured. Patient outcomes were assessed at 90 days. The diagnosis of pneumonia was made using strictly validated guidelines. A model using PCT was more accurate [area under the curve (AUC) 72.3] than any other individual clinical variable for the diagnosis of pneumonia in all patients, in those with obstructive lung disease, and in those with acute heart failure (AHF). Combining physician estimates of the probability of pneumonia with PCT values increased the accuracy to 86 for the diagnosis of pneumonia in all patients. Patients with a diagnosis of AHF and an elevated PCT concentration (0.21 ng/mL) had a worse outcome if not treated with antibiotics (P 0.046), while patients with low PCT values (0.05 ng/mL) had a better outcome if they did not receive antibiotic therapy (P 0.049). Procalcitonin may aid in the diagnosis of pneumonia, particularly in cases with high diagnostic uncertainty. Importantly, PCT may aid in the decision to administer antibiotic therapy to patients presenting with AHF in which clinical uncertainty exists regarding a superimposed bacterial infection. Trial registration: NCT00537628.Keywords
This publication has 14 references indexed in Scilit:
- Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute DyspneaJournal of the American College of Cardiology, 2010
- Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract InfectionsJAMA, 2009
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trialThe Lancet, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Influence of Deviation From Guidelines on the Outcome of Community-Acquired PneumoniaChest, 2002
- Regression Modeling StrategiesSpringer Series in Statistics, 2001
- A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unitIntensive Care Medicine, 1995
- Effects of prehospital medications on mortality and length of stay in congestive heart failureAnnals of Emergency Medicine, 1992
- Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort studyAmerican Journal Of Medicine, 1990